A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2b Study of OTO-104 Given as a Single Intratympanic Injection in Subjects with Unilateral Menieres Disease


This study is recruiting participants 18 - 80yo who have been diagnosed with unilateral Meniere's Disease and are experiencing vertigo. If you meet enrollment criteria, you will be randomized to receive an intratympanic (eardrum) injection of either the study drug (OTO-104) or a placebo and will attend 6 clinic visits over a 5 month period. For more information, please call Leigh Anne Marshall at 352.273.5178; email: leighanne.marshall@ent.ufl.edu


Menieres disease, vertigo, ear, ringing, dizzy

Principal Investigator

Patrick Antonelli, M.D.



Contact Information


Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams